Mylan says Teva offer too low and stock 'unacceptable'

(Reuters) - Mylan NV rejected Teva Pharmaceutical Industries Ltd's unsolicited $40 billion (£26.2 billion) takeover offer on Monday, saying it was too low and calling Teva stock an "unacceptable" currency. Mylan, which is pursuing its own takeover of Perrigo Co Plc, had been expected to reject the offer after having indicated that such a combination would not be a good fit. 'High-Risk Currency' Mylan Executive Chairman Rob Coury said in a lengthy letter to Teva released